Skip to content
Robert Charles Block, M.D., M.P.H.

Robert Charles Block, M.D., M.P.H.



4.8 out of 5 stars
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients


Appointment (585) 275-2877
Administrative (585) 275-8784


Cardiac Care

2400 South Clinton Avenue, 1st Floor
Rochester, NY 14618

About Me

Dr. Robert Block specializes in the care of patients with dyslipidemia. His expertise includes the diagnosis and treatment of patients with complex lipid disorders and familial cholesterol diseases. He is board certified in Internal Medicine, and also in Clinical Lipidology.

Faculty Appointments

Professor - Department of Public Health Sciences (SMD)

Professor - Center for Community Health and Prevention - Joint

Professor - Department of Medicine, Cardiology (SMD) - Joint


Residency & Fellowship

Fellowship, University of Rochester Medical Center. 2004 - 2006

Residency, Internal Medicine, Mayo Foundation Rochester. 1992 - 1995

Internship, Internal Medicine, Michigan State University Kalamazoo Center for Medical Studies. 1991 - 1992


MPH | University of Rochester School of Medicine/Dentistry. 2006

MD | New Jersey Medical School. 1991


Chapter President's Service Award. 2023

Interesting Opportunities Award. 2023

University of Rochester Strong Star Certificate of Appreciation. 2020

ICARE Award of Excellence for contributions to the Heart and Vascular Webinar. 2020

University of Rochester Strong Star Certificate of Appreciation. 2019

University of Rochester Strong Star Certificate of Appreciation. 2017

University of Rochester Strong Star Certificate of Appreciation. 2016

University of Rochester Strong Star Certificate of Appreciation. 2015

University of Rochester Strong Star Certificate of Appreciation. 2015

University of Rochester Strong Star Certificate of Appreciation. 2014

Gold Star Human. 2014

Excellence in Research Incentive Program Award. 2013

Strong Star Certificate of Appreciation. 2013

Excellence in Research Incentive Program Award. 2013

University of Rochester Strong Star Certificate of Appreciation. 2013

University of Rochester Strong Star Certificate of Appreciation. 2011

Sandra Daugherty Award for Excellence in Cardiovascular Disease or Hypertension Epidemiology. 2008

Community Health Improvement Clerkship (CHIC) recognized as an innovative element of the curriculum. Dr. Block was Co-Director.. 2008

Elizabeth Barrett-Connor Award Finalist. 2006

Dictator of the Year, Honorable Mention. 1997

Medical Student Research Award. 1987

Scudder Association Scholarship for students involved in humanitarian work. 1987

Scudder Association Scholarship for students involved in humanitarian work. 1986

Institutional Research and Academic Career Development Award (KL2) Scholar.

Dean's List, Multiple.

Honorable Mention, Dictator of the Year.




Research: The primary and secondary prevention of cardiovascular disease through public health measures and medical practice redesign as well as the investigation of pathophysiologic mechanisms by which disease develops. His sub-focus is the role of fatty acids and cardiovascular disease. Given his...
Research: The primary and secondary prevention of cardiovascular disease through public health measures and medical practice redesign as well as the investigation of pathophysiologic mechanisms by which disease develops. His sub-focus is the role of fatty acids and cardiovascular disease. Given his years of clinical practice, Dr. Block's research interests are quite broad. His research, however, focuses on the investigation of how nutrition affects the risk of cardiovascular disease. This interest is most intense regarding the role of fatty acids and their metabolites on heart disease risk, particularly in those with coronary artery disease. He has completed a recent study of the relationship of blood levels of omega-3 and omega-6 fatty acids and the risk of recurrent coronary artery events. He is interested in understanding the role of biomarkers, such as fatty acids, for clinical use as well as in helping to understand heart disease pathophysiology. He has published regarding the clinical use of measuring lipoprotein(a) in predicting risk of cardiovascular disease in different populations and regarding the need for an integrated approach to cardiovascular disease modification. His clinical, teaching, and research expertise merge to generate novel hypotheses, many of which involve patient perspectives and goals. With his students, he focuses on creating direct patient and public health experiences by having them shadow patient visits, participate in meetings, and collaborate on his research projects. His career interests translate into his daily life as well, as he often runs or bikes to work in order to advance the adoption of a healthy, preventive lifestyle.

Clinical Trials

EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction

Lead Researcher: Robert Block

This study is being done to learn whether regular healthcare, combined with early treatment with a cholesterol lowering drug called evolocumab (Repatha®) reduces heart attack, stroke, procedures to improve blood flow, and death, compared to regular h...

An Open-Label Safety Study of AKCEA-APOCIII-LRX Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen (ISIS 304801)

Lead Researcher: Robert Block

Familial Chylomicronemia Syndrome (FCS) is a rare genetic disease that causes high levels of fat in the blood. People with FCS have a high risk of developing pancreatitis, a serious condition that can lead to death. There is no cure for FCS, but trea...


Journal Articles

Polycystic Ovary Syndrome: A Review of Diagnosis and Management, with Special Focus on Atherosclerotic Cardiovascular Disease Prevention

Merle L. Myerson MD, EdD, FACC, FNLA*, Rodis D Paparodis MD, FNLA, Robert C. Block, MD, MPH, FACP, FNLA, Dean G. Karalis MD, FNLA, Guy Mintz MD, FACC, FNLA, Eliot A. Brinton MD, FAHA, FNLA, Robert Wild MD, PhD.

Journal of Clinical Lipidology. 2024; .

Integrative review of electrocardiographic characteristics in patients with reduced, mildly reduced, and preserved heart failure.

Pokhrel Bhattarai S, Block RC, Xue Y, Rodriguez DH, Tucker RG, Carey MG

Heart & lung : the journal of critical care.. 2023 October 3063 :142-158. Epub 10/30/2023.

Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study.

Clegg K, Schubert TJ, Block RC, Burke F, Desai NR, Greenfield R, Karalis D, Kris-Etherton PM, McNeal CJ, Nahrwold R, Peña JM, Plakogiannis R, Wong ND, Jones LK

Journal of clinical lipidology.. 2023 August 2 Epub 08/02/2023.

The association between genetically elevated polyunsaturated fatty acids and risk of cancer.

, Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, Tsilidis KK, Gaunt TR, Hemani G, Zheng J, Truong T, Birmann BM, OMara T, Spurdle AB, Iles MM, Law MH, Slager SL, Saberi Hosnijeh F, Mariosa D, Cotterchio M, Cerhan JR, Peters U, Enroth S, Gharahkhani P, Le Marchand L, Williams AC, Block RC, , , , , , , , , , , Amos CI, Hung RJ, Zheng W, Gunter MJ, Smith GD, Relton C, Martin RM

EBioMedicine.. 2023 April 2091 :104510. Epub 04/20/2023.

Indicators of Self-Determination in Therapeutic Songwriting Lyrics Created by Adults with High LDL Cholesterol.

Wojdak C, Silvey P, Coykendall C, Lin YS, Bansal A, Shannon K, Wagner H, McIntosh S, Block RC

Journal of music therapy.. 2023 March 18 Epub 03/18/2023.

Effects of a Pilot Music Therapy Intervention on Motivation in Patients with Severe Hypercholesterolemia

Nathan J, Wojdak C, Williams G, McIntosh S, Coykendall C, Lin Y, Thevenet-Morrison K, Block RC.

Music and Medicine. 2023; 15(3).

Frequency of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease

Upadhyaya B, Wang Y, Bruckel J, Block RC.

Journal of Clinical Lipidology. 2023; 17(4).

Integrative Review of Electrocardiographic Characteristics in Patients with Reduced, Mildly Reduced, and Preserved Heart Failure

Sunita Pokhrel Bhattarai Ph.D. Candidate RN MN, Robert Charles Block MD MPH, Ying Xue DNSc, RN, Darcey H Rodriguez MLISa, Rebecca G. Tucker RN, Ph.D., ACNP, Mary G Carey RN, Ph.D., FAHA FAAN.

Heart & Lung: HL-D-23-00694R1. 2023; .

Prevention and treatment of atherothrombosis: Potential impact of nanotechnology.

Nguyen AB, Iqbal O, Block RC, Mousa SA

Vascular pharmacology.. 2022 November 11 :107127. Epub 11/11/2022.

Statin therapy upregulates arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis.

Garshick MS, Block R, Drenkova K, Tawil M, James G, Brenna JT

Prostaglandins, leukotrienes, and essential fatty acids.. 2022 May 180 :102428. Epub 04/16/2022.

Photoplethysmography Fast Upstroke Time Intervals Can Be Useful Features for Cuff-Less Measurement of Blood Pressure Changes in Humans

Natarajan K.; Block RC; Yavarimanesh M; Chandrasekhar A; Mestha LK; Inan OT; Hahn J; Mukkamala R.

IEEE Transactions on Biomedical Engineering. 2022; 69(1): 53-62.

Is There a Role for Aspirin in Prevention in 2022?

Michael D. Cheshire; Robert C. Block.

LipidSpin. 2022; .

Pharmacotherapy for Dyslipidemia and Metabolic Dysfunction-Associated Steatotic Fatty Liver Disease

Baecher, N., Block, R. Pokrywka, G.

LipidSpin. 2022; .

Case study of hypertriglyceridemia from COVID-19 Pfizer-BioNTech vaccination in a patient with familial hypercholesteremia.

Cheung B, Hwang J, Stolarczyk A, Mahlof EN, Block RC

European review for medical and pharmacological sciences.. 2021 September 25 (17):5525-5528. Epub 1900 01 01.

Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.

Murphy KA, Harsch BA, Healy CL, Joshi SS, Huang S, Walker RE, Wagner BM, Ernste KM, Huang W, Block RC, Wright CD, Tintle N, Jensen BC, Wells QS, Shearer GC, O'Connell TD

Cardiovascular research.. 2021 March 22 Epub 03/22/2021.

Integrating Patient-Reported Outcomes into Clinical Genetic Testing for Familial Hypercholesterolemia

Hendricks-Sturrup R; Block RC; Lu C.

Journal of Patient-Centered Research and Reviews. 2021; 8(4): 336-9.

Aspirin and Omega-3 Polyunsaturated Fatty Acid Use and Their Interaction in Cardiovascular Diseases and Colorectal Adenomas

Wang I, Yi S*, Block R, Mousa S.

Nutrition Research Reviews. 2021; 13(1): 1-13.

Patient Voice and Health Education for Familial Hypercholesterolaemia

McIntosh S, Coykendall C, Lin YS, Caufield M, Muller J, Rowe T, and Block RC.

Health Education Journal. 2021; 81(2): 123-133.

Role of DNA methylation on the association between physical activity and cardiovascular diseases: results from the longitudinal multi-ethnic study of atherosclerosis (MESA) cohort

Shi H*, Ossip DJ, Mayo NL, Lopez DA, Block RC, Post WS, Bertoni AG, Ding J, Chen S, Yan C, Xie Z, Hoeschele I, Liu Y, Li D.

BMC Genomics. 2021; 22(1): 790. PMC8567593.

Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study

Block RC, Shearer GC, Holub A*, Tu XM, Mousa S, Brenna JT, Harris WS, Tintle N.

Prostaglandins Leukot Essent Fatty Acids. 2021; 169: 102283. PMC8159885.

Track and Field Injuries Resulting in Emergency Department Visits from 2004 through 2015: An Analysis of the National Electronic Injury Surveillance System

Mintz JJ*, Jones CMC, Seplaki CL, Rizzone KH, Thevenet-Morrison K, Block RC.

Phys Sportsmed. 2021; 49(1): 74-80.

Assessment of Calibration Models for Cuff-Less Blood Pressure Measurement After One Year of Aging

Yavarimanesh M**, Block RC**, Natarajan K, Mestha LK, Inan OT, Hahn JO, Mukkamala R (**indicates shared first authorship).

Transactions on Biomedical Engineering. 2021; 69(6): 2087-2093. PMC9154072.

Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey

Block RC, Bang M, Peterson A, Wong ND, Karalis DG.

J Clin Lipidol. 2021; 15(5): 682-689.

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia

Peterson AL, Bang M, Block RC, Wong ND, Karalis DG.

J Clin Med. 2021; 10(14): 3090. PMC8306062.

Biological changes in the pregnancy-postpartum period and subsequent cardiometabolic risk-UPSIDE MOMS: A research protocol

Groth SW, Fernandez ID, Block RC, Thurston SW, Wong E, Brunner J, Mayo N, Kapula N, Yu Y, Meng Y, Yeh KL, Kinkade CW, Thornburg LL, O'Connor TG, Barrett ES.

Res Nurs Health. 2021; 44(4): 608-619. PMC8378197.

Statin therapy upregulated arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis

Garshick M, Tawil M, LoSicco K, Brenna J, Block R, Berger J, James G.

Journal of Clinical Lipidology. 2021; 15(5): E8.

Conventional pulse transit times as markers of blood pressure changes in humans.

Block RC, Yavarimanesh M, Natarajan K, Carek A, Mousavi A, Chandrasekhar A, Kim CS, Zhu J, Schifitto G, Mestha LK, Inan OT, Hahn JO, Mukkamala R

Scientific reports.. 2020 October 210 (1):16373. Epub 10/02/2020.

Different mother and daughter manifestations due to very high cholesterol-containing lipoproteins.

Hwang J, Cheung B, Block RC

European review for medical and pharmacological sciences.. 2020 September 24 (17):9147-9150. Epub 1900 01 01.

Familial hypercholesterolemia

Hwang J, Block RC, Burgin S, Winter MW.

Visual Dx. 2020; .

A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia

Hendricks-Sturrup RM; Clark-LoCascio J; Lu C, Block RC (Acknowledged).

Journal of Personalized Medicine. 2020; 10(2): 23.

Technology's Importance for Patients with Potential Familial Hypercholesterolemia

McIntosh S, Coykendall C*, Lin YS, Ayers B*, Baghinyan A, Kaur M, Block RC. (Under Review).

Medical Education. 2020; .

Polypharmacy prior to in-hospital cardiac arrest among patients with cardiopulmonary diseases: A pilot study

Attin M, Abiola S, Magu R, Rosero S, Apostolakos M, Groth CM, Block R, Lin CDJ, Intrator O, Hurley D, Arcoleo K.

Resuscitation Plus. 2020; 4: 100026.

The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus

Holub A*, Mousa S, Abdolahi A*, Godugu K, Tu XM, Brenna JT, Block RC.

Nutr Metab Cardiovasc Dis. 2020; 30(10): 1795-1799. PMC7494550.

Glycerol derived process contaminants in refined coconut oil induce cholesterol synthesis in HepG2 cells.

Brenna JT, Wang X, Block RC, Park HG, Mendralla E, Wang Z, Kothapalli KSD, Cheng M, Liu R

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.. 2019 May 127 :135-142. Epub 03/13/2019.

Green space and mental health symptoms in a cardiac rehabilitation population. Indoor and Built Environment

Patel DM*, Block RC, Chapman BP, Korfmacher KS, van Wijngaarden E.

Indoor and Built Environment. 2019; 28(10): 1431-1440.

Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids: From MESA

Block RC, Liu L*, Herrington DM, Huang S, Tsai MY, O'Connell TD, Shearer GC.

JACC Heart Fail. 2019; 7(8): 651-661.

Interlaboratory Assessment of Dried Blood Spot Fatty Acid Compositions

Metherel AH, Harris WS, Ge L, Gibson RA, Chouinard-Watkins R, Bazinet RP, Liu L, Brenna JT, Aristizabal-Henao JJ, Stark KD, Block RC.

Lipids. 2019; 54(11-12): 755-761.

Genetic testing for a patient with suspected familial hypercholesterolaemia

Mudgundi V*, Williams G, Manou K, Block R.

BMJ Case Rep. 2018; : 2018:bcr2018225259. PMC6058112.

Do elevated blood levels of omega-3 fatty acids modify effects of particulate air pollutants on fibrinogen?

Croft D, Block R, Cameron SJ, Evans K, Lowenstein CJ, Ling F, Zareba W, Hopke PK, Utell MJ, Thurston SW, Thevenet-Morrison K, Rich DQ

Air quality, atmosphere, & health.. 2018 11 (7):791-799. Epub 06/03/2018.

Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann Cohort.

Adams MJ, Fisher SG, Lipshultz SE, Shore RE, Constine LS, Stovall M, Dozier A, Thevenet-Morrison K, Block R, Schwartz RG, Pearson TA

Cardio-oncology.. 2018 4 Epub 02/17/2018.

Brief report of virtual clinician research tools for tobacco dependence or dyslipidemia.

Williams GC, Lowenstein L, Cox JF, Patrick H, Adams MJ, Block RC, Rigby CS

Journal of health psychology.. 2017 September 22 (11):1463-1468. Epub 02/29/2016.

Linking lysosomal acid lipase insufficiency to the development of cryptogenic cirrhosis.

Block RC, Razani B

Atherosclerosis.. 2017 July 262 :140-142. Epub 04/25/2017.

Micronutrient Intake Is Inadequate for a Sample of Pregnant African-American Women.

Groth SW, Stewart PA, Ossip DJ, Block RC, Wixom N, Fernandez ID

Journal of the Academy of Nutrition and Dietetics.. 2017 April 117 (4):589-598. Epub 01/05/2017.

?3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

O'Connell TD, Block RC, Huang SP, Shearer GC

Journal of molecular and cellular cardiology.. 2017 February 103 :74-92. Epub 12/14/2016.

Familial hypercholesterolaemia patient–determined themes for community-engaged research

DeAngelis E*, McIntosh S, Ahmed C, Block R.

Health Education Journal. 2017; 77(3): 293-302.

Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study

Peoples AR*, Roscoe JA, Block RC, Heckler CE, Ryan JL, Mustian KM, Janelsins MC, Peppone LJ, Moore DF Jr, Coles C, Hoelzer KL, Morrow GR, Dozier AM.

Support Care Cancer. 2017; 25(4): 1271-1278. PMC5323277.

Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus

Block RC, Holub A*, Abdolahi A*, Tu XM, Mousa SA, Oda MN.

Prostaglandins Leukot Essent Fatty Acids. 2017; 126: 25-31. PMC5683419.

Immediate and Sustained Decrease in Smoking Urges After Acute Insular Cortex Damage

Abdolahi A*, Williams GC, Benesch CG, Wang HZ, Spitzer EM, Scott BE, Block RC, van Wijngaarden E.

Nicotine Tob Res. 2017; 19(6): 756-762. PMC5896541.

Blood Pressure and Left Ventricular Mass Index Among Healthy Adolescents

Daimee UA, Lande MB, Tang W, Tu XM, Veazie P, Bisognano JD, Block R, Teeters JC*.

Blood Press Monit. 2017; 22(1): 48-50.

Academic Dysfunction After a Concussion Among US High School and College Students

Wasserman EB*, Bazarian JJ, Mapstone M, Block R, van Wijngaarden E.

Am J Public Health. 2016; 106(7): 1247-53. PMC4984778.

Prior hospital admission predicts thirty-day hospital readmission for heart failure patients

McLaren DP*, Jones R, Plotnik R, Zareba W, McIntosh S, Alexis J, Chen L, Block R, Lowenstein CJ, Kutyifa V.

Cardiol J. 2016; 23(2): 155-62.

Increases in ambient particulate matter air pollution, acute changes in platelet function, and effect modification by aspirin and omega-3 fatty acids: A panel study.

Becerra AZ, Georas S, Brenna JT, Hopke PK, Kane C, Chalupa D, Frampton MW, Block R, Rich DQ

Journal of toxicology and environmental health. Part A.. 2016 79 (6):287-98. Epub 03/30/2016.

Options to consider when treating lysosomal acid lipase deficiency.

Block RC, Razani B

Journal of clinical lipidology.. 2016 10 (5):1280-1. Epub 07/25/2016.

Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis

Augustine EF*, Adams HR, Beck CA, Vierhile A, Kwon J, Rothberg PG, Marshall F, Block R, Dolan J, Mink JW; Batten Study Group.

Dev Med Child Neurol. 2015; 57(4): 366-71. PMC4610252.

Smoking cessation behaviors three months following acute insular damage from stroke

Abdolahi A*, Williams GC, Benesch CG, Wang HZ, Spitzer EM, Scott BE, Block RC, van Wijngaarden E.

Addict Behav. 2015; 51: 24-30. PMC4558299.

Damage to the insula leads to decreased nicotine withdrawal during abstinence

Abdolahi A*, Williams GC, Benesch CG, Wang HZ, Spitzer EM, Scott BE, Block RC, van Wijngaarden E.

Addiction. 2015; 110(12): 1994-2003. PMC4644476.

The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA

Block RC, Abdolahi A*, Tu X, Georas SN, Brenna JT, Phipps RP, Lawrence P, Mousa SA.

Prostaglandins Leukot Essent Fatty Acids. 2015; 96: 17-24. PMC4395522.

Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors

Sprod LK*, Fernandez ID, Janelsins MC, Peppone LJ, Atkins JN, Giguere J, Block R, Mustian KM.

J Geriatr Oncol. 2015; 6(1): 8-14. PMC4297736.

Preoperative Brain Natriuretic Peptide and Atrial Arrhythmias After Coronary Artery Bypass Graft Surgery

Bernstein E*, Block R, Veazie P, Tompkins C, Bashour CA, Turan A.

Journal of Cardiothoracic and Vascular Anesthesia. 2015; 29(3): 11-616.

A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.

Cameron SJ, Daimee U, Block RC

European review for medical and pharmacological sciences.. 2015 19 (14):2628-2633. Epub 1900 01 01.

Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation.

Schuchardt JP, Neubronner J, Block RC, Schacky CV, Hahn A

Prostaglandins, leukotrienes, and essential fatty acids.. 2014 October 91 (4):129-34. Epub 07/23/2014.

The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus

Abdolahi A*, Georas SN, Brenna JT, Cai X, Thevenet-Morrison K, Phipps RP, Lawrence P, Mousa SA, Block RC.

Prostaglandins Leukot Essent Fatty Acids. 2014; 90(2-3): 61-8. PMC3939709.

Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.

Augustine AH, Lowenstein LM, Harris WS, Shearer GC, Block RC

Prostaglandins, leukotrienes, and essential fatty acids.. 2014 90 (2-3):69-75. Epub 12/18/2013.

International service and public health learning objectives for medical students.

Block RC, Duron V, Creigh P, McIntosh S

Health education journal.. 2013 September 172 (5):530-536. Epub 1900 01 01.

Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus

Block RC, Abdolahi A*, Smith B, Meednu N, Thevenet-Morrison K, Cai X, Cui H, Mousa S, Brenna JT, Georas S.

Prostaglandins Leukot Essent Fatty Acids. 2013; 89(1): 9-18. PMC3683095.

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population

Kakinami L*, Block RC, Adams MJ, Cohn SE, Maliakkal B, Fisher SG.

Int J Clin Pract. 2013; 67(1): 6-13. PMC3533243.

Severe coronary disease in an adult considered at low cardiovascular disease risk with a healthy lifestyle.

Cameron SJ, Block RC, Richeson JF

Journal of clinical lipidology.. 2013 7 (5):526-30. Epub 05/28/2013.

Associations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-2008 National Health and Nutrition Examination Survey.

Hoffmire CA, Block RC, Thevenet-Morrison K, van Wijngaarden E

Prostaglandins, leukotrienes, and essential fatty acids.. 2012 April 86 (4-5):155-60. Epub 04/01/2012.

Omega-3 fatty acids EPA and DHA: health benefits throughout life.

Swanson D, Block R, Mousa SA

Advances in nutrition.. 2012 January 3 (1):1-7. Epub 01/05/2012.

Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients

Kakinami L*, Adams MJ, Block RC, Cohn SE, Maliakkal B, Fisher SG.

AIDS Res Hum Retroviruses. 2012; 28(12): 1552-6. PMC3505066.

Cis-vaccenic acid and the Framingham risk score predict chronic kidney disease: the multi-ethnic study of atherosclerosis (MESA)

Block R, Kakinami L*, Liebman S, Shearer GC, Kramer H, Tsai M.

Prostaglandins Leukot Essent Fatty Acids. 2012; 86(4-5): 175-82. PMC3340522.

The Effects of EPA+DHA and Aspirin on Inflammatory Cytokines and Angiogenesis Factors

Block RC, Dier U, CalderonArtero P*, Shearer GC, Kakinami L*, Larson MK, Harris WS, Georas S, Mousa SA.

World J Cardiovasc Dis. 2012; 2(1): 14-19. PMC3331709.

The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans

Block RC, Kakinami L*, Jonovich M, Antonetti I, Lawrence P, Meednu N, CalderonArtero P*, Mousa SA, Brenna JT, Georas S.

Prostaglandins Leukot Essent Fatty Acids. 2012; 87(4-5): 143-51. PMC3589139.

Carotid endarterectomy and carotid artery stenting utilization trends over time

Skerritt MR*, Block RC, Pearson TA, Young KC.

BMC Neurol. 2012; 12: 17. PMC3355040.

Fish oil metabolites: translating promising findings from bench to bedside to reduce cardiovascular disease

CalderonArtero P*, Champagne C, Garigen S, Mousa S, Block R.

J Glycomics Lipidomics. 2012; 2(1): 1000106. PMC3372925.

An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007.

Block RC, Dozier AM, Hazel-Fernandez L, Guido JJ, Pearson TA

Preventing chronic disease.. 2012 9 :E90. Epub 04/19/2012.

Fatty acids in cardiovascular health and disease: a comprehensive update.

Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, Whelan J, Ramsden CE, Block RC

Journal of clinical lipidology.. 2012 6 (3):216-34. Epub 04/13/2012.

Integrating the Chronic Care Model into a Novel Medical Student Course.

Block RC, Tran B, McIntosh S

Health education journal.. 2011 March 70 (1):39-47. Epub 1900 01 01.

Greasing the wheels of managing overweight and obesity with omega-3 fatty acids

Golub N, Geba D*, Mousa SA, Williams G, Block RC.

Medical Hypotheses. 2011; 77(6): 1114-20. PMC3210336.

Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease

Ramli J, CalderonArtero P*, Block RC, Mousa SA.

Cardiol J. 2011; 18(4): 352-63. PMC3342824.

Impact of communication on preventive services among deaf American Sign Language users

McKee MM*, Barnett SL, Block RC, Pearson TA.

Am J Prev Med. 2011; 41(1): 75-9. PMC3117257.

Our expanding view of platelet functions and its clinical implications.

Ombrello C, Block RC, Morrell CN

Journal of cardiovascular translational research.. 2010 October 3 (5):538-46. Epub 07/27/2010.

The relationship between retinal microvascular abnormalities and coronary heart disease: a review.

McClintic BR, McClintic JI, Bisognano JD, Block RC

The American journal of medicine.. 2010 April 123 (4):374.e1-7. Epub 1900 01 01.

Parenteral fish oil-associated burr cell anemia.

Mallah HS, Brown MR, Rossi TM, Block RC

The Journal of pediatrics.. 2010 February 156 (2):324-6.e1. Epub 1900 01 01.

High Density Lipoprotein (HDL) Modulation Targets.

Mousa SS, Block RC, Mousa SA

Drugs of the future. 2010 January 35 (1):33-39. Epub 1900 01 01.

Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators

Sherazi S*, Zareba W, Daubert JP, McNitt S, Shah AH, Aktas MK, Block RC.

Cardiol J. 2010; 17(3): 267-73. PMC3337764.

The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin

Block RC, Duff R, Lawrence P, Kakinami L*, Brenna JT, Shearer GC, Meednu N, Mousa S, Friedman A, Harris WS, Larson M, Georas S.

Prostaglandins Leukot Essent Fatty Acids. 2010; 82(2-3): 87-95. PMC2926929.

Altered cholesterol and fatty acid metabolism in Huntington disease.

Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I

Journal of clinical lipidology.. 2010 4 (1):17-23. Epub 1900 01 01.

The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Block R, Corsetti J, Goldenberg I, Vorobiof G, McNitt S, Ryan D, Zareba W, Moss AJ

Heart international. 2009 June 304 (1):e8. Epub 1900 01 01.

Lp(a) and risk of recurrent cardiac events in obese postinfarction patients.

Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE

Obesity.. 2008 December 16 (12):2717-22. Epub 10/16/2008.

Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?

Block RC, Harris WS, Reid KJ, Spertus JA

American heart journal.. 2008 December 156 (6):1117-23. Epub 10/14/2008.

Cardiovascular Health in the Developing World: Community Perceptions from Carriacou, Grenada.

Dozier AM, Block R, Levy D, Dye TD, Pearson TA

CVD prevention and control. 2008 September 13 (3):123-131. Epub 1900 01 01.

EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls.

Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA

Atherosclerosis.. 2008 April 197 (2):821-8. Epub 09/17/2007.

Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester.

McIntosh S, Block RC, Kapsak G, Pearson TA

Academic medicine : journal of the Association of American Medical Colleges.. 2008 April 83 (4):357-64. Epub 1900 01 01.

Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator

Sherazi S*, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR, Haley JM, Shah AH.

Mayo Clin Proc. 2008; 83(10): 1139-41.

Determinants of Blood Cell Omega-3 Fatty Acid Content.

Block RC, Harris WS, Pottala JV

The open biomarkers journal. 2008 1 :1-6. Epub 1900 01 01.

Impact of a community health improvement clerkship project.

Quinn L, Block R, McIntosh S

Medical education.. 2007 November 41 (11):1102-3. Epub 09/19/2007.

Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers.

Goldenberg I, Moss AJ, Block R, Ryan D, Corsetti JP, McNitt S, Eberly SW, Zareba W

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.. 2007 October 12 (4):364-74. Epub 1900 01 01.

Organizing services for cardiovascular prevention.

Block RC, Pearson TA

Current treatment options in cardiovascular medicine.. 2007 August 9 (4):278-86. Epub 1900 01 01.

The cardiovascular implications of omega-3 fatty acids

Block RC, Pearson TA.

Cardiology Journal. 2006; 13(7): 557-569.

Lipoprotein(a): implications for clinical practice.

Block RC, Pearson TA

Current atherosclerosis reports.. 2005 September 7 (5):327-9. Epub 1900 01 01.

Foreign Body: An Unexpected Finding

Block, RC.

Consultant. 1996; : 380.

Modulation of nicotine-induced analgesia by calcium agonist and antagonist in adult rats.

Chin CW, Block RC, Wu WH, Zbuzek VK

Psychopharmacology.. 1993 110 (4):497-9. Epub 1900 01 01.

Nicotine-induced analgesia in rats: the role of calcium and the diversity of responders and nonresponders.

Block RC, Chin CW, Wu W, Zbuzek VK

Life sciences.. 1993 53 (12):PL195-200. Epub 1900 01 01.


Angiogenesis Modulation by Arachidonic (2013)

Chapter: Angiogenesis Modulations in Health and Disease

Authors: Block RC, Yalcin M, Srinivasan M, Georas S, Mousa SA.

Publisher: Springer Science+Business Media, Dordrecht 2013

"Hyperlipidemia". Manual of Outpatient Cardiology (2012)

Authors: Woolf K, Connell R, Block R

Publisher: Springer-Verlag, London 2012

Rochester Heart Failure Book (2009)

Chapter: The Prevention of Ischemic Heart Disease

Authors: Sherazi S, Block RC

Publisher: Springer 2009

Textbook of Cardiovascular Medicine (2007)

Chapter: An Integrated Approach to Risk Factor Modification

Authors: Block RC, Pearson TA

Publisher: Lippincott, Williams & Wilkens, Philadelphia 2007

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.


During this visit, did this provider spend enough time with you?

4.8 stars

During this visit, did this provider show respect for what you had to say?

4.9 stars

During this visit, did this provider give you easy to understand information about these health questions or concerns?

4.8 stars

During this visit, did this provider listen carefully to you?

4.8 stars

During this visit, did this provider explain things in a way that was easy to understand?

4.8 stars

Patient Comments

5.0 stars

Dr. Block is truly the best!

Feb 26, 2024

5.0 stars

Care provider supplied me with literature to help me make informed decision on my care.

Nov 21, 2023

5.0 stars

Dr Block was very pleasant and knowledgeable about my condition and gave me a plan to follow plus Information on how to contact him for any questions or problems.

Nov 18, 2023

5.0 stars

Happy with all my healthcare providers at U of R Medical.

Aug 21, 2023

5.0 stars

Dr. Block always explains everything clearly and answers all my (and my husband's) questions completely...I know that he Is trying to keep me In good to great health.

Jun 23, 2023

5.0 stars

Dr. Block is awesome! He listens, he is smart, and he knows what he is talking about.

Apr 29, 2023

5.0 stars

This was my first time seeing Dr Block but he was wonderful. Very caring, extremely smart and took his time in my appointment.

Apr 29, 2023

5.0 stars

Exceptional experience with Dr Block - I am extremely grateful he is part of my medical team. He listens, and treats me with the utmost respect.

Mar 18, 2023

4.6 stars

I appreciate that the provider invited the team pharmacist in to discuss the medication he wanted me to take.

Feb 16, 2023

5.0 stars

One of the most exceptional doctors I have ever known; he is extremely knowledgeable and helpful. Just a wonderful person and doctor!

Feb 12, 2023


Dr. Block has helped me immensely with my cholesterol control. Listening carefully and allowing me to feel comfortable with the treatment plan.

Feb 02, 2023


Exceptional medical provider - we are lucky to have him here in Rochester.

Dec 22, 2022


He and his colleague who led the visit were wonderful

Dec 21, 2022


One of the best doctors I have ever had!

Dec 16, 2022


The provider is very knowledgeable and listens to my concerns. [...] This provider is very well prepared , very knowledgeable and very clinically sound.

Dec 14, 2022



Aug 13, 2022


Dr. Block was wonderful. He talked about cholesterol, my meds & answered all my questions!

Jul 21, 2022


Jun 10, 2022


Professional, conversational, understanding and kind

Apr 15, 2022


Very good appointment. Good communication

Mar 27, 2022


First time seeing Dr. Block and his resident Jeannie. Very happy with all aspects of the visit. They are friendly and knowledgeable, and had plenty of time to answer any questions or explain things. Being seen exactly on time was very refreshing! No wait for anything.

Feb 18, 2022


Dr. Block gave me some take home info for further clarification. - Very helpful!

Feb 15, 2022